Qijiong Li

5PUBLICATIONS
17CO-AUTHORS
ChemotherapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 29, 2026
Hepatic Arterial Infusion Chemotherapy Plus Systemic Chemotherapy, Lenvatinib and PD-(L)1 Inhibitors Versus Systemic Chemotherapy Plus PD-(L)1 Inhibitors in Advanced Intrahepatic Cholangiocarcinoma.

|Dec 08, 2025
HBV Reactivation in Patients with Hepatocellular Carcinoma Treated with PD-1/-L1 Antibodies and Concurrent Antiviral Prophylaxis Agents: A Prospective Observational Study.

Zefeng Du, Zhicheng Lai, Yexing Huang

|Oct 11, 2023
Lenvatinib, Toripalimab plus FOLFOX Chemotherapy in Hepatocellular Carcinoma Patients with Extrahepatic Metastasis: A Biomolecular Exploratory, Phase II Trial (LTSC).

MinKe He, YeXing Huang, ZeFeng Du

|Dec 19, 2022
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials.

YeXing Huang, LiHong Zhang, MinKe He

|Dec 13, 2021
Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma.

Yu-Jie Xu, Zhi-Cheng Lai, Min-Ke He

Pageof 1

Frequent Collaborators

3 joint publications

Anna Kan

2 joint publications

MinKe He

2 joint publications

YeXing Huang

2 joint publications

ZeFeng Du